Showing results (1511-1520 of 2,575) with videos related to

Sort By:
Pageof 258
Current Medical Research and Opinion|April 13, 2018
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) studyRobert Zivadinov, Nasreen Khan, Jonathan R Korn, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2009
Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onsetE A Yeh, B Weinstock-Guttman, N Lincoff, et al.
Journal of Neuroimmunology|October 28, 2008
Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patientsBianca Weinstock-Guttman, Kavitha Bhasi, Darlene Badgett, et al.
BMC Medical Ethics|January 13, 2017
Navigating social and ethical challenges of biobanking for human microbiome researchKim H Chuong, David M Hwang, D Elizabeth Tullis, et al.
Frontiers in Neurology|November 12, 2020
Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple SclerosisNicole Ziliotto, Robert Zivadinov, Dejan Jakimovski, et al.
Neuroimage. Clinical|January 20, 2021
Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changesDejan Jakimovski, Robert Zivadinov, Niels Bergsland, et al.
Journal of Surgical Education|April 14, 2019
Compassion Fatigue in Surgical TraineesNatashia M Seemann, Paul J Karanicolas, Matthew P Guttman, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|August 19, 2018
Abnormal venous postural control: multiple sclerosis-specific change related to gray matter pathology or age-related neurodegenerative phenomena?Dejan Jakimovski, Matthew Topolski, Kana Kimura, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 2, 2019
Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple SclerosisMichael G Dwyer, Niels Bergsland, Deepa P Ramasamy, et al.
Therapeutic Advances in Neurological Disorders|May 6, 2015
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosisRobert Zivadinov, Michael Dwyer, Silva Markovic-Plese, et al.
Pageof 258